Study: PET/MRI shows promise in restaging of prostate cancer

12/26/2012 | AuntMinnie.com (free registration)

Choline-PET/MRI identified more suspicious lesions compared with PET/CT in 31 patients with recurrent prostate cancer, according to a study presented at a radiology meeting. The study also found that PET/MRI performs comparably with PET/CT in identifying lymph node metastases and bone metastases. The findings indicate a fully diagnostic choline-PET/MRI protocol for restaging prostate cancer is well-tolerated and feasible in patients, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide